已发表论文

KPC-2、LAP-2 和 CTX-M-65 在中国 ST1469 多重耐药肺炎克雷伯菌菌株中共存

 

Authors Chen C, Shi Q, Hu X, Liu X, Liu Y, Liu R

Received 5 October 2022

Accepted for publication 14 November 2022

Published 22 November 2022 Volume 2022:15 Pages 6731—6737

DOI https://doi.org/10.2147/IDR.S392063

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Professor Suresh Antony

Purpose: Beta-lactamase-producing Klebsiella pneumoniae is common in the clinic, but research associated with the co-existence of KPC-2, LAP-2, and CTX-M-65 in K. pneumoniae is still rare. In this study, the phenotypic and genetic characteristics of a multidrug-resistant K. pneumoniae strain SJ25 co-harboring bla KPC-2bla LAP-2, and bla CTX-M-65 with rare ST1469 were investigated.
Methods and Results: Antimicrobial susceptibility testing revealed that strain SJ25 was resistant to various common antibiotics, except ciprofloxacin, fosfomycin, colistin, and tigecycline. Whole-genome analysis revealed that strain SJ25 carries a variety of antimicrobial resistance genes and virulence determinants. Plasmid analysis confirmed that the bla KPC-2 and bla CTX-M-65 genes were located on an ~136 kb transferrable IncFII/IncR plasmid and that bla LAP-2 was located on an untypeable plasmid.
Conclusion: Our findings emphasized the need for continuous surveillance of β-lactamase-bearing K. pneumoniae in the clinic to control potential dissemination and outbreak.
Keywords: Klebsiella pneumoniae , multidrug-resistant, bla KPC-2bla LAP-2bla CTX-M-65